Proteasome impairment in neural cells derived from HMSN-P patient iPSCs

scientific article published on 15 February 2017

Proteasome impairment in neural cells derived from HMSN-P patient iPSCs is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1083783244
P356DOI10.1186/S13041-017-0286-Y
P932PMC publication ID5310050
P698PubMed publication ID28196470

P50authorHaruhisa InoueQ88139486
Haruhisa InoueQ96238987
P2093author name stringTakuya Yamamoto
Toshitaka Kawarai
Ryuji Kaji
Yuishin Izumi
Kayoko Tsukita
Naohiro Egawa
Keiko Imamura
Nagahisa Murakami
Takako Enami
P2860cites workSeamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposonQ48925635
Brainstem and spinal cord motor neuron involvement with optineurin inclusions in proximal-dominant hereditary motor and sensory neuropathyQ48952235
Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes.Q50624483
Cutadapt removes adapter sequences from high-throughput sequencing readsQ55953584
A new type of hereditary motor and sensory neuropathy linked to chromosome 3Q73428664
Impaired proteasome function in Alzheimer's diseaseQ73897101
Hereditary motor and sensory neuropathy (proximal dominant form, HMSN-P) among Brazilians of Japanese ancestryQ80977720
Optinurin inclusions in proximal hereditary motor and sensory neuropathy (HMSN-P): familial amyotrophic lateral sclerosis with sensory neuronopathy?Q84992006
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsQ21999527
Fast gapped-read alignment with Bowtie 2Q27860699
Induction of pluripotent stem cells from adult human fibroblasts by defined factorsQ27860967
A perspective on stem cell modeling of amyotrophic lateral sclerosisQ28080614
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Q29547403
HTSeq--a Python framework to work with high-throughput sequencing dataQ29614489
Protein degradation and protection against misfolded or damaged proteinsQ29618400
Creating Patient-Specific Neural Cells for the In Vitro Study of Brain DisordersQ30278015
Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structureQ30538198
Genetic background drives transcriptional variation in human induced pluripotent stem cellsQ33716774
Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBacQ34153816
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvementQ34293334
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cellsQ34314350
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signalingQ34506149
Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entryQ35177001
Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A.Q35225590
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneuronsQ35802889
New lessons learned from disease modeling with induced pluripotent stem cellsQ36374130
iPS cell technologies: significance and applications to CNS regeneration and diseaseQ37688424
Induced pluripotent stem cells: a new revolution for clinical neurology?Q37857439
Misfolded PrP and a novel mechanism of proteasome inhibitionQ37997568
iPS cells: a game changer for future medicineQ38185513
TFG-Related Neurologic Disorders: New Insights Into Relationships Between Endoplasmic Reticulum and NeurodegenerationQ38761524
TFG clusters COPII-coated transport carriers and promotes early secretory pathway organizationQ38920273
Evidence of TRK-Fused Gene (TFG1) function in the ubiquitin-proteasome systemQ39016939
Prion-like properties of pathological TDP-43 aggregates from diseased brainsQ39129644
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cellsQ39910905
Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutationQ39910909
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cellsQ41857309
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.Q41873090
TFG-1 function in protein secretion and oncogenesisQ42056487
Drug screening for ALS using patient-specific induced pluripotent stem cellsQ42820289
Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging processQ43179672
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal functionQ44292891
A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG functionQ48238432
P433issue1
P304page(s)7
P577publication date2017-02-15
P1433published inMolecular BrainQ6895938
P1476titleProteasome impairment in neural cells derived from HMSN-P patient iPSCs
P478volume10

Reverse relations

cites work (P2860)
Q38711908Editing the genome of hiPSC with CRISPR/Cas9: disease models
Q52431351Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Q58594046Stem Cells, Genome Editing, and the Path to Translational Medicine
Q55021463The natural history of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in 97 Japanese patients.
Q57816866Unraveling the Role of Heme in Neurodegeneration

Search more.